Long noncoding RNA-miRNA-mRNA axes multiple roles in osteosarcoma

被引：4
作者：
Malakoti, Faezeh [1 ,2 ]
Alemi, Forough [1 ]
Karimzadeh, Haniye [3 ,4 ]
Asemi, Zatollah [5 ]
Asadi, Milad [6 ]
Ghobadi, Hadi [1 ]
Soleimanpour, Jafar [7 ]
Yousefi, Bahman [1 ]
机构：
[1] Tabriz Univ Med Sci, Dept Biochem & Clin Labs, Fac Med, Tabriz, Iran
[2] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Iran
[3] Isfahan Univ Med Sci, Sch Pharm, Dept Clin Biochem, Esfahan, Iran
[4] Isfahan Univ Med Sci, Isfahan Pharmaceut Sci Res Ctr, Esfahan, Iran
[5] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran
[6] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[7] Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran
来源：
GENE REPORTS | 2021年 / 23卷
关键词：
lncRNA; Osteosarcoma; Cancer diagnosis; Signaling pathway; Gene therapy; PROMOTES CELL-PROLIFERATION; ADENOCARCINOMA TRANSCRIPT 1; POOR-PROGNOSIS; INHIBITS PROLIFERATION; SIGNALING PATHWAY; MALAT1; PROMOTES; DOWN-REGULATION; UP-REGULATION; METASTASIS; PROGRESSION;
D O I：
10.1016/j.genrep.2021.101090
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Osteosarcoma is the most predominant primary bone malignant tumor in adolescents, characterized by high tumor mortality and poor treatment ratio. Long noncoding RNAs (lncRNAs) have important roles in key cell biological events encompassing differentiation, proliferation, development, invasion, and migration which accomplish this task by regulating genome functions including transcription, splicing, and epigenetics. Besides, some lncRNAs have been recently connected with the emergence of malignancy, and also important events involved in the cancer treatment process, such as drug sensitivity and resistance. In this article, we reviewed the effects of lncRNAs on osteosarcoma cells progression, prognosis, and drug resistance by modulating miRNAs and signaling pathways.
引用
收藏
页数：10
相关论文
共 105 条
[1]   Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery [J].
Amreddy, Narsireddy ;
Babu, Anish ;
Muralidharan, Ranganayaki ;
Panneerselvam, Janani ;
Srivastava, Akhil ;
Ahmed, Rebaz ;
Mehta, Meghna ;
Munshi, Anupama ;
Ramesh, Rajagopal .
ADVANCES IN CANCER RESEARCH, VOL 137, 2018, 137 :115-170
[2]   Update on Survival in Osteosarcoma [J].
Anderson, Megan E. .
ORTHOPEDIC CLINICS OF NORTH AMERICA, 2016, 47 (01) :283-+
[3]   Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy [J].
Angulo, Pablo ;
Kaushik, Gaurav ;
Subramaniam, Dharmalingam ;
Dandawate, Prasad ;
Neville, Kathleen ;
Chastain, Katherine ;
Anant, Shrikant .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
[4]  
Biazzo A, 2016, ACTA ORTHOP BELG, V82, P690
[5]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790
[6]   Control of Chromatin Structure by Long Noncoding RNA [J].
Boehmdorfer, Gudrun ;
Wierzbicki, Andrzej T. .
TRENDS IN CELL BIOLOGY, 2015, 25 (10) :623-632
[7]   Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression [J].
Chan, L. H. ;
Wang, W. ;
Yeung, W. ;
Deng, Y. ;
Yuan, P. ;
Mak, K. K. .
ONCOGENE, 2014, 33 (40) :4857-4866
[8]   Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma [J].
Chen, Shunguang ;
Xu, Xiaoming ;
Lu, Shengjun ;
Hu, Biao .
ONCOLOGY LETTERS, 2019, 18 (02) :1323-1329
[9]  
Chen Zhixu, 2018, Oncotarget, V9, P26770, DOI 10.18632/oncotarget.24247
[10]   Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p [J].
Cheng, F-H ;
Zhao, Z-S ;
Liu, W-D .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (17) :7256-7265
12345678910